C STRATEGIC TEC (01725) September revenue approximately RMB 58.61 million
China Strategic Technology Group (01725) announced that, based on the company's preliminary accounting, the group's unaudited revenue for September 2026 was approximately RMB 58.61 million.
C STRATEGIC TEC (01725) announced that, based on the Company's preliminary accounting, the Group's unaudited revenue for September 2026 was approximately RMB 58.61 million.
Related Articles
US Stock Market Move | U.S. clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) debuted on the U.S. stock market, with its share price falling more than 10% after the opening bell.
US Stock Market Move | Trex Bio (TRXB.US) debuts on the U.S. stock market, falling more than 1.3% after the open.
US Stock Market Move | Included in the Nasdaq 100 Index, Moderna (MRNA.US) rises 7%.
US Stock Market Move | U.S. clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) debuted on the U.S. stock market, with its share price falling more than 10% after the opening bell.
US Stock Market Move | Trex Bio (TRXB.US) debuts on the U.S. stock market, falling more than 1.3% after the open.
US Stock Market Move | Included in the Nasdaq 100 Index, Moderna (MRNA.US) rises 7%.
